Whitepapers

Learn about how sponsors and sites can identify and overcome barriers to participation and implement strategies to diversify their clinical trials.

Read this whitepaper to learn about key considerations pharmacovigilance teams examine when evaluating new safety solutions. 

Watch and learn how The McCreadie Group and endpoint experts offer a solution to the current struggles IDS sites and sponsors have been facing.

endpoint’s VP, data and Quality, Cat Hall shares key questions you might be missing that help ensure your IRT provider is focused on quality first.

This session, led by endpoint’s VP of Data and Quality, Cat Hall discusses how efficient clinical trial design strategies that expedite the development of oncology drugs and biologics are necessary.

This case study demonstrates how Medable eConsent enabled greater patient access to a trial, improved trial operations and time to treatment.

This white paper describes a framework for leveraging data, analytics, and patient insights for optimal design of clinical trials.

How are sponsors empowering sites to reach their full potential in 2021?

Automating study start-up enables faster site activation, better collaboration with study partners, and more informed decision-making. That’s why sponsors and contract research organizations (CROs) are turning to technology specifically designed to manage the intricacies of study start-up.

Learn how you can improve cost and process efficiencies and make it easier for pharmacovigilance teams to perform advanced tasks.

Read this white paper on navigating the complexities of today’s increasingly complicated clinical trials. Consider the services your study needs for success.

Every successful clinical trial must protect patients while collecting complete, accurate data that supports evaluation of the safety and effectiveness of the drug or device. Here’s a closer look at why data and safety managers are so important to a clinical trial, what can go wrong when they aren’t aligned and how to improve collaboration between them.

Discover how a small pharmaceutical company leveraged unified visualizations and reporting into study data to save $50M in study costs and months in development time.

Insmed had a late-breaking strategy change that challenged their timelines. Learn how they incorporated significant protocol changes and still hit their FPI deadline.

Which new developments can help jump-start breakthroughs in immuno-oncology research? Understand the key scientific drivers, read peer-reviewed research, and get actionable ideas that can spur innovation in this must-read paper for clinical leaders.

In the wake of COVID-19, clinical research sites are in dire need of extra resources to help run their clinical trials. By utilizing qualified, experienced WCG Clinical Research Coordinators (CRCs), these professionals can help overburdened study teams get tasks done, and get them done with efficiency and precision.

Discover how a small pharmaceutical company leveraged unified visualizations and reporting into study data to save $50M in study costs and months in development time.

Private practices tap into an industry investing more than $15 billion annually in the USA. These five recommendations help practices capitalize on potential benefits.

Cerba Research initiated custom kit building & distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.